Analysis of Clinical Efficacy of Azithromycin Combined Glucocorticoids in Treatment of Severe Pneumonia Mycoplasma / 现代生物医学进展
Progress in Modern Biomedicine
; (24): 5079-5082,5137, 2017.
Article
in Zh
| WPRIM
| ID: wpr-606900
Responsible library:
WPRO
ABSTRACT
Objective:
To analyze the influences of azithromycinantibiotic combined glucocorticoids on the levels of erythrocyte sedimentation rate (ESR),serum lactate dehydrogenase (LDH) and inflammatory cytokines levels as well as the clinical effect of severe pneumonia mycoplasma.Methods:
112 children with severe pneumonia mycoplasma who were treated in our hospital were selected and randomly divided into the control group and the observation group with 56 cases in each group.The patients in the control group were treated with azithromycinantibiotic,while the patients in the observation group were treated with glucocorticoid on the basis of the control group.Then the levels of ESR,LDH,isoenzyme MB (CK-MB),creatine kinase (CK),aspertate aminotransferase (AST),c-reactive protein (CRP),interleukin 6 (IL-6),tumor necrosis factor-o (TNF-α),CD4+ and CD8+,the clinical efficacy and adverse reactions between two groups were observed and compared before and after the treatment.Results:
The effective rate in the observation group was higher than that of the control group,and the difference was statistically significant (P<0.05).After treatment,the levels of ESR,LDH,CK-MB,CK,AST,CRP,IL-6,TNF-α and CD8+ in the two groups decreased,which were lower in the observation group than those of the control group (P<0.05).After treatment,the levels of CD4+ in both groups increased,which was higher in the observation group than that of the control group (P<0.05).The disappearance time of fever,cough relief,lung rale of observation group were shorter than those of the control group(P<0.05).There was no statistically significant difference in the adverse reactions between the two groups (P>0.05).Conclusion:
Azithromycin combined with glucocorticoids was more effective than azithromycin alone in the treatment of severe mycoplasma pneumonia with high safety,which could obviously relieve the myocardial injury and inflammatory response,enhance the immune function.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Progress in Modern Biomedicine
Year:
2017
Type:
Article